Fig. 3.
![Fig. 3. Whole blood coagulation and ASA. / Comparison of whole blood coagulation before (▪) and after (●) administration of ASA, 2 × 325 mg/d for 3 consecutive days. Coagulation was initiated in whole blood by 25 pM relipidated TF as described in “Materials and methods.” Panel A represents thrombin (TAT) generation, panel B fibrin (FPA) formation, and panel C platelet activation (osteonectin [ON] release). Arrow “a” indicates clotting times before ASA administration, arrow “b” after.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/97/8/10.1182_blood.v97.8.2314/5/h80810935003.jpeg?Expires=1735834847&Signature=3GCMCUXptkT6juMo1ZqJeNMIVgzI8fKtmtlhpZYHf454RAgcuHwZIxqUajc1hMrmMHxa303ESVPjg0Cv16sFdhyCKWwMnt4XytQw-PxOH3kP8fhMKZKycYR9ElWtl3VOwl3WTinXV9O1rS05xpyHtgbu3UOhpkVtYztpb6yeDe7ABzIKuTdjDQBfsEgj3DoFjRIfFSU4m0giUAMdxBYXtRoka2hp5SMId-INpGSMZ3mT2c~CgWXl-jLh2xzOnHf07sKgBGe9lVSUJ1ssC-gXndxePhoRwaqF9TyQGZ8xRaTTmSLA6xX5ZHQ8GboFDG5-sOlyPyg0dvFnsxNbOYvN4w__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Whole blood coagulation and ASA.
Comparison of whole blood coagulation before (▪) and after (●) administration of ASA, 2 × 325 mg/d for 3 consecutive days. Coagulation was initiated in whole blood by 25 pM relipidated TF as described in “Materials and methods.” Panel A represents thrombin (TAT) generation, panel B fibrin (FPA) formation, and panel C platelet activation (osteonectin [ON] release). Arrow “a” indicates clotting times before ASA administration, arrow “b” after.
